Please login to the form below
New Accounts, July, 2009, PR & Med Ed
New pharmaceutical account wins notified to us by the winning agency for the period May 2009 and July 2009 inclusive
New pharmaceutical account wins notified to us by the winning agency for the period May 2009 and July 2009 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| AstraZeneca | N/A | Non-small cell lung cancer | Medaxial Group |
| AZ/BMS | Onglyza | Diabetes | Virgo HEALTH |
| Almirall | Solaraze | Dermatology | Signature Healthcare Communications |
| Biogen Idec | N/A | Neurology | Medaxial Group |
| BMS | Patient support | HIV | Hive |
| Boehringer Ingelheim | CME | Non-small cell lung cancer | Strategic Consultants International |
| The Hesley Group | N/A | Corporate | Clew Communications |
| Cranage Healthcare International | New product | Dermatology | Signature Healthcare Communications |
| Galderma | New product | Dermatology | Signature Healthcare Communications |
| GSK | Cervarix | Cervical cancer | Virgo HEALTH |
| IDIS | European and UK corporate | Corporate | Ogilvy Healthworld UK |
| Mundipharma | Strategic planning processes and European internal comms engagement | Corporate | JYC Global |
| Napp Pharmaceuticals | Oxycontin | Palliative Care | Signature Healthcare Communications |
| Novartis | NHS engagement | Diabetes, Hypertension, CV | JYC Global |
| Nutricia Advanced Medical Nutrition | Respifor | COPD | Virgo HEALTH |
| Nutricia Advanced Medical Nutrition | Conference support | Cross-brand | Virgo HEALTH |
| Orchid | Male cancer awareness week | Corporate | Spink |
| Schering-Plough | NHS project work | Cardiovascular | JYC Global |
| SKCIN | Corporate | Skin cancer | Signature Healthcare Communications |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
No results were found
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients
- Moderna completes enrolment of phase 3 COVID-19 vaccine trial
- Vaccine developers call on FDA to offer clarity on COVID-19 trials
- The other side of … blood cancer
- COVID-19 – a catalyst for technology adoption in clinical trials
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
- The other side of … blood cancer
- To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
- COVID-19 – a catalyst for technology adoption in clinical trials
- As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...
Quick links
Infographics
